DMACVSSXTC• 28 Days (Normalized)
DMAC vs SXTC (DiaMedica Therapeutics Inc. vs China SXT Pharmaceuticals Inc.)
Showing Closing Date Range from Sep 11 to Oct 9, 2026.
Normalized cumulative comparison anchored at 0.00% baseline to illustrate pure alpha, return divergence, and market momentum.
DMAC Performance $8.33
+28.75%
DiaMedica Therapeutics Inc.
Normalized Baseline0.00%
SXTC Performance $0.15
-94.18%
China SXT Pharmaceuticals Inc.
Normalized Baseline0.00%
Alpha Spread Margin DMAC LEADS
+122.93 pts
DMAC outperforming by 122.93 percentage points
DMACSXTC
Spread Trajectory28 Days (Normalized)
Cumulative Performance Trajectory
Interactive divergence comparison normalized at 0.00% on start date.
DMAC SXTC
Comparative Historical Ledger
Daily closing prices, normalized percentages, and relative spread divergence.
Historical Quotes & Breakdown(21 dates)
| Date | DMAC Price | DMAC Gain (%) | SXTC Price | SXTC Gain (%) | Spread |
|---|---|---|---|---|---|
| Oct 09, 2026 | $8.33 | +28.75% | $0.15 | -94.18% | +122.93% |
| Oct 08, 2026 | $8.01 | +23.80% | $0.34 | -86.56% | +110.36% |
| Oct 07, 2026 | $7.99 | +23.49% | $2.83 | +10.55% | +12.94% |
| Oct 06, 2026 | $8.13 | +25.66% | $1.25 | -51.17% | +76.83% |
| Oct 05, 2026 | $8.42 | +30.14% | $2.08 | -18.75% | +48.89% |
| Oct 02, 2026 | $8.23 | +27.20% | $2.41 | -5.86% | +33.06% |
| Oct 01, 2026 | $- | $2.96 | +15.62% | - | |
| Sep 30, 2026 | $- | $3.01 | +17.58% | - | |
| Sep 29, 2026 | $- | $2.81 | +9.77% | - | |
| Sep 28, 2026 | $- | $2.52 | -1.56% | - | |
| Sep 25, 2026 | $7.70 | +19.01% | $- | - | |
| Sep 24, 2026 | $7.83 | +21.02% | $- | - | |
| Sep 23, 2026 | $7.56 | +16.85% | $2.51 | -1.95% | +18.80% |
| Sep 22, 2026 | $7.78 | +20.25% | $- | - | |
| Sep 21, 2026 | $7.26 | +12.21% | $2.38 | -7.03% | +19.24% |
Page 1 of 2